The GEPIA and TCGA databases were used to analyze the role of NOD2 in the development of melanoma, and it was found that the expression of NOD2 was significantly downregulated in melanoma compared to normal tissue, especially in metastatic melanoma patients with lower expression levels (Fig. 1A, B). The gene discussed is NOD2; the disease is metastatic melanoma.